PL2644191T3 - Membrana włókninowa jako układ dostarczania leku - Google Patents

Membrana włókninowa jako układ dostarczania leku

Info

Publication number
PL2644191T3
PL2644191T3 PL12162338T PL12162338T PL2644191T3 PL 2644191 T3 PL2644191 T3 PL 2644191T3 PL 12162338 T PL12162338 T PL 12162338T PL 12162338 T PL12162338 T PL 12162338T PL 2644191 T3 PL2644191 T3 PL 2644191T3
Authority
PL
Poland
Prior art keywords
delivery system
drug delivery
nonwoven membrane
nonwoven
membrane
Prior art date
Application number
PL12162338T
Other languages
English (en)
Inventor
Garcia Jose Antonio Tornero
Carcaboso Angel Montero
Llavina Joan Bertran
Original Assignee
Universitat Politécnica de Catalunya
Hospital Sant Joan De Deu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitat Politécnica de Catalunya, Hospital Sant Joan De Deu filed Critical Universitat Politécnica de Catalunya
Publication of PL2644191T3 publication Critical patent/PL2644191T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D10/00—Physical treatment of artificial filaments or the like during manufacture, i.e. during a continuous production process before the filaments have been collected
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F11/00—Chemical after-treatment of artificial filaments or the like during manufacture
    • D01F11/04—Chemical after-treatment of artificial filaments or the like during manufacture of synthetic polymers
    • D01F11/08—Chemical after-treatment of artificial filaments or the like during manufacture of synthetic polymers of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
    • D04H3/016—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the fineness
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H5/00—Non woven fabrics formed of mixtures of relatively short fibres and yarns or like filamentary material of substantial length
    • D04H5/02—Non woven fabrics formed of mixtures of relatively short fibres and yarns or like filamentary material of substantial length strengthened or consolidated by mechanical methods, e.g. needling
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
    • D10B2331/04—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyesters, e.g. polyethylene terephthalate [PET]
    • D10B2331/041—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyesters, e.g. polyethylene terephthalate [PET] derived from hydroxy-carboxylic acids, e.g. lactones
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00—Medical; Hygiene

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Textile Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL12162338T 2012-03-30 2012-03-30 Membrana włókninowa jako układ dostarczania leku PL2644191T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12162338.3A EP2644191B1 (en) 2012-03-30 2012-03-30 Nonwoven membrane as a drug delivery system

Publications (1)

Publication Number Publication Date
PL2644191T3 true PL2644191T3 (pl) 2017-08-31

Family

ID=48014000

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12162338T PL2644191T3 (pl) 2012-03-30 2012-03-30 Membrana włókninowa jako układ dostarczania leku
PL16178875T PL3108881T3 (pl) 2012-03-30 2012-03-30 Membrana włókninowa jako układ dostarczania leków

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL16178875T PL3108881T3 (pl) 2012-03-30 2012-03-30 Membrana włókninowa jako układ dostarczania leków

Country Status (10)

Country Link
US (1) US9561190B2 (pl)
EP (2) EP3108881B1 (pl)
CN (2) CN104321051B (pl)
DK (1) DK3108881T3 (pl)
ES (2) ES2690483T3 (pl)
HR (1) HRP20181676T1 (pl)
PL (2) PL2644191T3 (pl)
PT (1) PT3108881T (pl)
TR (1) TR201815577T4 (pl)
WO (1) WO2013144206A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9814786B2 (en) 2013-12-02 2017-11-14 Nicolai Bovin Functionalizing nanofibres
CN104018294B (zh) * 2014-04-10 2016-06-22 中国科学院宁波材料技术与工程研究所 一种聚乳酸纳米纤维膜及其制备方法
KR20170044647A (ko) * 2014-08-04 2017-04-25 오스피탈 산트 호안 데 데우 활성제의 즉시 방출을 위한 시스템
US12397082B2 (en) * 2015-06-01 2025-08-26 Amogreentech Co., Ltd. Antimicrobial dressing
KR101810080B1 (ko) * 2015-06-01 2017-12-19 주식회사 아모라이프사이언스 치과용 멤브레인
KR101810079B1 (ko) * 2015-06-01 2017-12-19 주식회사 아모그린텍 항균 드레싱
US11219390B2 (en) * 2015-08-03 2022-01-11 Georgetown University Apparatus and method for delivery of antimicrobial during a transdermal sampling and delivery process
CA2999973A1 (en) * 2015-08-31 2017-03-09 Cormedix Inc. Delivery of active agents using nanofiber webs
ES2584405A1 (es) * 2016-06-08 2016-09-27 Universitat Politècnica De València Compuesto no tejido bioelastómero
US20180000744A1 (en) * 2016-06-30 2018-01-04 Georgia Southern Research and Service Foundation, Inc. Nanoencapsulated compositions
US11001943B1 (en) * 2016-08-08 2021-05-11 University Of Georgia Research Foundation, Inc. Nanofiber spinning apparatus and method
HUP1600505A2 (en) * 2016-08-30 2018-03-28 Semmelweis Egyetem Multilayer adhesive
CN107142610B (zh) * 2017-05-18 2019-10-11 四川大学 一种高性能立构复合聚乳酸静电纺丝纳米纤维膜及其制备方法
CN107556717A (zh) * 2017-09-30 2018-01-09 江苏瑞腾涂装科技有限公司 一种聚乳酸组合物
EP3829549B1 (en) 2018-08-03 2022-10-12 Cebiotex, S.L. Beaded nonwoven membrane as a drug delivery system
CN110487673B (zh) * 2019-08-09 2021-10-08 上海化工研究院有限公司 一种定量测定超高分子量聚乙烯树脂缠结程度的方法
CN110468503B (zh) * 2019-08-22 2022-02-15 河南省人民医院 一种复合纳米纤维膜及其制备方法和应用
IT202000002836A1 (it) * 2020-02-13 2021-08-13 Bakel S R L Prodotto cosmetico
JP7518179B2 (ja) * 2020-03-02 2024-07-17 イーエルシー マネージメント エルエルシー 化粧剤の送達、化粧用組成物、及びそれらの使用
CN111394806B (zh) * 2020-04-20 2023-07-18 南京工业职业技术学院 一种立体纤维膜制备装置及制备方法
WO2022020660A1 (en) * 2020-07-23 2022-01-27 Purdue Research Foundation Ozone generation apparatuses and methods of treating wounds
EP4180559A1 (en) 2021-11-10 2023-05-17 Asociacion Centro Tecnologico Ceit Drug delivery system using electrospinning of polymers
AU2023242296A1 (en) 2022-03-28 2024-09-19 Gate2Brain, S.L. Peptidic water-soluble delivery system of anticancer drugs
EP4518878A2 (en) * 2022-05-05 2025-03-12 Aion Healthspan, Inc. Nanomaterial-stem cell compositions and methods of use
CN117815185A (zh) * 2022-06-09 2024-04-05 张天平 一种脂质纳米纤维微粒及其制备方法
WO2024184189A1 (en) * 2023-03-03 2024-09-12 Danmarks Tekniske Universitet Monodisperse nanofibrous microparticles for delivery of one or more active substances

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020096246A1 (en) * 1999-10-06 2002-07-25 Michael S. Sennet Non-woven elastic microporous membranes
US20050158362A1 (en) * 2000-06-23 2005-07-21 Wheatley Margaret A. Polymeric, fiber matrix delivery systems for bioactive compounds
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
US20060094320A1 (en) * 2004-11-02 2006-05-04 Kimberly-Clark Worldwide, Inc. Gradient nanofiber materials and methods for making same
US20100055154A1 (en) 2006-07-24 2010-03-04 I-Chien Liao Coaxial electrospun fibers and structures and methods of forming the same
US8445018B2 (en) * 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US8114834B2 (en) 2006-11-09 2012-02-14 Northwestern University Self-assembling peptide amphiphiles
WO2009064767A2 (en) 2007-11-12 2009-05-22 Massachusetts Institute Of Technology Bactericidal nanofibers, and methods of use thereof
US8367109B2 (en) * 2008-04-09 2013-02-05 Brookhaven Science Associates, Llc Microbes encapsulated within crosslinkable polymers
WO2009133059A2 (en) 2008-05-02 2009-11-05 Evonik Degussa Gmbh Nanofiber matrices formed from electrospun hyperbranched polymers
US20120093717A1 (en) 2009-02-21 2012-04-19 The Trustees Of The University Of Pennsylvania Microsphere/nanofiber composites for delivery of drugs, growth factors, and other agents

Also Published As

Publication number Publication date
CN104321051A (zh) 2015-01-28
WO2013144206A1 (en) 2013-10-03
US9561190B2 (en) 2017-02-07
ES2601454T3 (es) 2017-02-15
CN104321051B (zh) 2018-09-18
PT3108881T (pt) 2018-11-12
CN108992432A (zh) 2018-12-14
HRP20181676T1 (hr) 2018-12-14
EP2644191B1 (en) 2016-08-03
CN108992432B (zh) 2022-02-11
EP3108881A1 (en) 2016-12-28
DK3108881T3 (en) 2018-11-12
TR201815577T4 (tr) 2018-11-21
US20150072008A1 (en) 2015-03-12
EP2644191A1 (en) 2013-10-02
ES2690483T3 (es) 2018-11-21
EP3108881B1 (en) 2018-07-25
PL3108881T3 (pl) 2018-12-31

Similar Documents

Publication Publication Date Title
HRP20181676T1 (hr) Nepletena membrana kao sustav dostave lijeka
EP2838511A4 (en) OCULAR MEDICATION DELIVERY SYSTEM
ZA201502352B (en) Liposomal drug delivery system
IL236746B (en) Drug release device
IL236745A0 (en) Drug release device
GB201215193D0 (en) Order delivery system
SI3081249T1 (sl) Naprava za dajanje zdravila
EP2830693A4 (en) NARCOSEGAS DELIVERY SYSTEM
ZA201504964B (en) Transdermal delivery system
ZA201309156B (en) Drug delivery system
EP2921152A4 (en) DRUG DELIVERY SYSTEM
EP2842539A4 (en) DRUG DELIVERY SYSTEM
SG10201607358WA (en) A novel drug delivery system based on jcv-vlp
ZA201406206B (en) A drug delivery system
IL234912A0 (en) Drug release device
SG10201609440WA (en) Multi-additive delivery system
GB201214708D0 (en) Secure delivery system
HUE049546T2 (hu) Gyógyszerbejuttató eszköz
HUE049542T2 (hu) Gyógyszerbejuttató eszköz
GB201218668D0 (en) Drug delivery device